Pharmafile Logo
Pharmafocus logo
Advanced Search

Study initiated for first miniaturised robotic-assisted surgery platform

April 20, 2022
Research and Development

Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …

News

NHS Health Chief calls for return of facemasks and social distancing

April 20, 2022
Research and Development

Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …

News

AstraZeneca drug granted FDA Priority Review

April 19, 2022
Manufacturing and Production

AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …

News

FDA accept New Drug Application for GSK’s daprodustat

April 19, 2022
Manufacturing and Production

GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …

News

VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial

April 13, 2022
Research and Development

VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …

News

NICE recommends avelumab for urothelial cancer patients

April 13, 2022
Research and Development

NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …

News

FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall

April 13, 2022
Research and Development

The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …

News

It could take up to six years to clear the patient backlog in Europe

April 13, 2022
Research and Development

Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …

News

Tjaopack announces completion of Netherlands facility expansion

April 12, 2022
Manufacturing and Production

Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …

News

Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs

April 12, 2022
Manufacturing and Production

NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …

News

VR solution for personalised treatment and surgery guidance to spine surgeons

April 12, 2022
Manufacturing and Production

Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …

News
nhs_sign

SMC accepts Inrebic for treatment of splenomegaly and myelofibrosis

April 12, 2022

The SMC has accepted Inrebic (fedratinib) for use witin NHS Scotland, for the treatment of disease-related splenomegaly (enlarged spleen). It …

News

Recipharm announces closing of acquisitions of two major CDMOs

April 11, 2022
Sales and Marketing

Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …

News

Innovative therapy ‘tricks’ and destroys cancer cells

April 11, 2022
Sales and Marketing

A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …

News

World leaders pledge $4.8 billion in 2022 Break COVID Now Summit

April 11, 2022
Sales and Marketing

World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …

News

‘Killer’ immunotherapy shows early promise

April 11, 2022
Sales and Marketing

A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …

News

NICE publishes guidance for atopic dermatitis treatments

April 8, 2022
Medical Communications

Abrocitinib, upadacitinib, and tralokinumab are not recommended for treating moderate to severe atopic dermatitis. The recommendation does not affect patients …

News

First-of-its-kind vaccine manufacturing facility shipped to Africa

April 8, 2022
Medical Communications

KeyPlants announced the shipping a first-of-its-kind vaccine manufacturing filling facility to Senegal, in West Africa.

News

Acadia seeks first-ever FDA approval in Rett Syndrome

April 8, 2022
Medical Communications

Acadia has presented an update on its Phase III LAVENDER study of trofinetide for Rett Syndrome at the American Academy …

News

NIH funds tuberculosis research advancement centres

April 8, 2022
Medical Communications

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026